[Present status and prospects of platelet inhibitors].
D000241:Adenosine / Q000378:metabolism; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D000242:Cyclic AMP / Q000502:physiology; D006152:Cyclic GMP / Q000502:physiology; D003864:Depression, Chemical; D004338:Drug Combinations; D004357:Drug Synergism; D006801:Humans; D010726:Phosphodiesterase Inhibitors; D010974:Platelet Aggregation / Q000187:drug effects; D011458:Prostaglandins E / Q000494:pharmacology / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism; D013806:Theophylline / Q000494:pharmacology; D013927:Thrombosis / Q000188:drug therapy
D004338:Drug Combinations; D010726:Phosphodiesterase Inhibitors; D011458:Prostaglandins E; D012701:Serotonin; D013806:Theophylline; D000242:Cyclic AMP; D006152:Cyclic GMP; D000241:Adenosine; D001241:Aspirin